ABOUT THE 12th ANNUAL EUROPEAN LIFE SCIENCES CEO FORUM
Back for its 12th Annual edition, this global bio-pharma industry forum addresses through its conference programme the main challenges for 2019 in investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in the different therapeutic sectors. The forum also features keynote speeches by KOL and about 60 selected corporate presentations from established (public and private) and emerging biotechs seeking to promote investment and partnering opportunities. We expect over 350 delegates to attend the event. The forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities. We anticipate more than 1500 face-to-face meetings to take place throughout 2 days.
This year, following our conference, in the afternoon of the 26th we will also host the 1st GoforIsrael Life Sciences Conference. We will bring together leading global investors and Israel’s best opportunities from the Life Sciences industry, addressing current issues related to raising capital and establishing strategic alliances in Europe. The companies taking part in the GoforIsrael part of the Sachs ELSCEO forum will be leading Israeli companies in the fields of MedTech, Biotech, Pharmaceuticals, Diagnostics, and Digital Health.
Plenary Sessions include:
China-Europe Partnering & Investment Panel
Early Stage Investor Roundtable
“Latest Trends in Fund Raising & Investment” – Private Equity & VC Panel
Pharma DealMakers Roundtable
“Prospects for 2019”- Global Biopharma Industry Review Panel
Kevin Pan, Co-Founder, Chairman & CEO, Asieris Pharmaceuticals
Markus Hosang, General Partner, BioMedPartners AG
Markus Kalousek, Head of Pharma Search & Evaluation, Global BD&L, Novartis Pharma AG
Matthias Müllenbeck, Director Global Oncology L&BD, Global BD & Alliance Management, Merck KGaA
Michael Altorfer, CEO, Swiss Biotech Association
Michel Wurm, VP, Medical Affairs, Strategy & BD, Pharmaleads SA
Mirko Scherer, Managing Partner, TVM Capital China Ltd.
Nathalie ter Wengel, European Head External R&D and Innovation, Pfizer, Inc.
Nicholas Franco, EVP & CBDO, Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson
Nigel Sheail, Head of Global Business Development & Licensing, Novartis Pharma AG
Olav Hellebo, CEO, ReNeuron Group Plc.
Olivier Litzka, Partner, ANDERA PARTNERS
Olivier Reinhard, Global Head of BD & Licensing, General Medicines and Emerging Markets, Sanofi
Patrick Benz, Senior Director Alliance Management, the Janssen Pharmaceutical Companies of Johnson & Johnson
Phil L'Huillier, Head of BD, Europe & Middle East, MSD
Pierre Vandepapelière, CEO & CMO, Imcyse SA
Rainer Strohmenger, General Partner, Wellington Partners
Sarah Holland, Head of Licensing, Pharma and Biotech, Lonza AG
Simon Blake, Senior Director, Scientific Licensing, the Janssen Pharmaceutical Companies of Johnson & Johnson
Stephan Lensky, COO & CBO, EpimAb Biotherapeutics, Inc.
Stephanie Léouzon, Partner and Head of Torreya Partners Europe, Torreya Partners (Europe) LLP
Stewart Kay, Director, Business Development, GlaxoSmithKline
Tim Haines, Managing Partner, Abingworth LLP
Timothy Luker, VP, Emerging Technology & Innovation, BD, Eli Lilly and Company
Torsten Mummenbrauer, Senior Vice President Business Development, Management, Hookipa Biotech GmbH
Yochi Slonim, Co-Founder, CEO, Anima Biotech, Inc.
And more TBA...
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at 12th Annual European Life Sciences CEO Forum & Exhibition is an effective way to gain leads, introduce new products and services, expand sales, and build relationships. Exhibition space is very limited - express your interest to secure the area.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
PARTICIPATING PHARMAS IN 2018:
FINANCIAL, ADVISORY, INVESTORS IN 2018: Abingworth LLP AGLAIA BioMedical Ventures B.V. Apex Healthcare Consulting Ltd. ATGN Consulting BAG Health Care GmbH Bellevue Asset Management AG BioMedPartners AG BioSeed Capital Bpifrance Breslin AG Capricorn Venture Partners NV Corinthian Financial Edmond de Rothschild Investment Partners Management LTD Creathor Ventures Creathor Ventures Csendes Consulting DDF Ventures Ernst & Young AG European Investment Bank European Investment Fund EVA - the Basel life sciences start-up agency Gilde Healthcare Partners goetzpartners (Schweiz) AG Grabulovski Consulting Services GrowthCube Partners, LLC HBM Partners AG HealthCare Royalty Partners High-Tech Gruenderfonds Management GmbH IBB Beteiligungsgesellschaft GmbH ICF Consult Industrifonden Isis Innovation/University of Oxford (BF) Jefferies International Limited Johnson & Johnson Innovation Kronos Advisors LSP LSRI Medex Capital Merck Ventures B.V. MSC Capital Nextech Invest Ltd. Norgine Ventures Management Limited Novartis Venture Fund Novo Holdings A/S Novo Seeds Novo Ventures Oddo BHF OrbiMed Advisors, LLC Peppermint Venture Partners GmbH PharmaVentures Ltd. Privateq Advisors AG Redalpine Venture Partners Rosetta Capital Ltd. Rothschild Seventure Partners Silicon Valley Bank Sofimac Partners Sofinnova Partners SA Staatz Business Development & Strategy